2024-03-28T23:09:04Z
http://repoint.unil.ch/oaiprovider/
oai:serval.unil.ch:BIB_D59B0D3DD07F
2024-03-23T03:02:52Z
serval:BIB_D59B0D3DD07F
Low TCR avidity and lack of tumor cell recognition in CD8(+) T cells primed with the CEA-analogue CAP1-6D peptide.
10.1007/s00262-007-0342-z
17564703
000249916900011
Iero
M.
author
Squarcina
P.
author
Romero
P.
author
Guillaume
P.
author
Scarselli
E.
author
Cerino
R.
author
Carrabba
M.
author
Toutirais
O.
author
Parmiani
G.
author
Rivoltini
L.
author
article
2007
Cancer immunology, immunotherapy
0340-7004
journal
56
12
1979-1991
Antibody Affinity
Antigens, Neoplasm/chemistry
CD8-Positive T-Lymphocytes/immunology
CD8-Positive T-Lymphocytes/metabolism
Cancer Vaccines
Colorectal Neoplasms/metabolism
Epitopes/chemistry
HLA-A Antigens/chemistry
Immunotherapy/methods
Leukocytes, Mononuclear/metabolism
Ligands
Oligopeptides/chemistry
Peptides/chemistry
Receptors, Antigen, T-Cell/immunology
Risk
T-Lymphocytes/metabolism
eng
60_published
peer-reviewed
Publication types: Journal Article ; Research Support, Non-U.S. Gov't
Publication Status: ppublish